This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Assia Chemical Industries Ltd., Watson Laboratories Inc.. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Innovations by Inventor Mendelovici Marioara in Pharmaceutical Chemistry
Introduction
Mendelovici Marioara, based in Rehovot, Israel, is an accomplished inventor known for his contributions in the field of pharmaceutical chemistry. With two patents to his name, Mendelovici has made significant advancements in the preparation of short-acting benzodiazepines, particularly Remimazolam.
Latest Patents
Mendelovici's latest patents include a detailed process for the preparation of Remimazolam and solid-state forms of Remimazolam salts. The disclosures reveal novel processes for synthesizing Methyl 3-[(4S)-8-bromo-1-methyl-6-(pyridin-2-yl)-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate, commonly known as Remimazolam. His work also encompasses the development of solid-state forms of Remimazolam salts, including processes for their preparation, as well as the formulation and methods of use for these pharmaceutical compositions.
Career Highlights
Throughout his career, Mendelovici has worked with prominent companies in the industry, such as Assia Chemical Industries Ltd. and Watson Laboratories Inc. His experiences in these organizations have significantly contributed to his expertise in pharmaceutical innovations and patent development.
Collaborations
Mendelovici has collaborated with skilled professionals, including Dolitzky Ben-Zion and Bodkhe Arjun Rajaram. These collaborations have fostered a productive environment, enabling the exchange of ideas and the advancement of innovative solutions within the pharmaceutical realm.
Conclusion
With his remarkable innovations and substantial contributions to the pharmaceutical sector, Mendelovici Marioara exemplifies the spirit of modern invention. His work not only enhances the field of short-acting benzodiazepines but also underscores the importance of collaboration in driving technological advancements in medicine. As he continues to evolve his research and development efforts, Mendelovici remains a key figure in the landscape of pharmaceutical inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile